Indication

Postencephalitic parkinsonism

Postencephalitic parkinsonism is a secondary form of parkinsonism that develops as a delayed neurodegenerative sequela following a viral central nervous system infection, historically most prominent among survivors of encephalitis lethargica. Read more about Postencephalitic parkinsonism

165 drugs 110 manufacturers

Advertisement

Drugs that treat it

Common Postencephalitic parkinsonism therapies.

Showing 91–99 of 165 drugs

LODOSYN (carbidopa)

ANTIPARKINSON ADJUVANT - PERIPHERAL DOPA-DECARBOXYLASE INHIB·PARKINSONISM·+2
Bausch Health US

CARBIDOPA

ANTIPARKINSON ADJUVANT - PERIPHERAL DOPA-DECARBOXYLASE INHIB·PARKINSONISM·+2
NORTHSTAR RX LL
Filter & compare in the drug finder →Opens the drug finder with Postencephalitic parkinsonism preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Postencephalitic parkinsonism.

Postencephalitic parkinsonism is a secondary form of parkinsonism that develops as a delayed neurodegenerative sequela following a viral central nervous system infection, historically most prominent among survivors of encephalitis lethargica.

The condition primarily impacts the extrapyramidal motor system through the progressive loss of dopaminergic neurons within the substantia nigra and midbrain networks.

Clinically, affected individuals exhibit classic features such as bradykinesia, muscular rigidity, postural instability, and tremors, frequently accompanied by distinctive manifestations like oculogyric crises, cranial neuropathies, and behavioral disturbances.

Pathophysiologically, it is characterized by neurofibrillary tangles and tau pathology in the basal ganglia and brainstem in the absence of the Lewy bodies and alpha-synuclein aggregates typically observed in idiopathic Parkinson disease.

Personalize your experience

Follow Postencephalitic parkinsonism and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it